Showing results (981-990 of 999) with videos related to

Sort By:
Pageof 100
JAMA Cardiology|March 26, 2025
Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use: A Subgroup Analysis of the OCEANIC-AF Randomized Clinical TrialJohn H Alexander, Elizabeth J Lydon, Jonathan P Piccini, et al.
Cancer Immunology Research|May 28, 2015
Long-term Benefit of PD-L1 Blockade in Lung Cancer Associated with JAK3 ActivationEliezer M Van Allen, Hadrien G Golay, Yan Liu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2019
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancerK Hastings, H A Yu, W Wei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2017
Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled TrialMalcolm D Mason, Noel W Clarke, Nicholas D James, et al.
Nature Medicine|July 25, 2018
Tumor innate immunity primed by specific interferon-stimulated endogenous retrovirusesIsrael Cañadas, Rohit Thummalapalli, Jong Wook Kim, et al.
JCI Insight|November 10, 2025
Minimalistic transcriptomic signatures permit accurate early prediction of COVID-19 mortalityRithwik Narendra, Emily C Lydon, Hoang Van Phan, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2025
Minimalistic Transcriptomic Signatures Permit Accurate Early Prediction of COVID-19 MortalityRithwik Narendra, Emily C Lydon, Hoang Van Phan, et al.
Plos Medicine|June 7, 2022
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trialChris C Parker, Nicholas D James, Christopher D Brawley, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 27, 2017
Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine studyArezou A Ghazani, Nelly M Oliver, Joseph P St Pierre, et al.
Lancet (London, England)|December 26, 2021
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocolGerhardt Attard, Laura Murphy, Noel W Clarke, et al.
Pageof 100